» Articles » PMID: 28008308

The Protective Role of MicroRNA-200c in Alzheimer's Disease Pathologies Is Induced by Beta Amyloid-Triggered Endoplasmic Reticulum Stress

Overview
Specialty Molecular Biology
Date 2016 Dec 24
PMID 28008308
Citations 30
Authors
Affiliations
Soon will be listed here.
Abstract

MicroRNAs are small non-coding RNAs that repress the expression of their target proteins. The roles of microRNAs in the development of Alzheimer's disease (AD) are not clear. In this study we show that miR-200c represses the expression of PTEN protein. PTEN downregulation by miR-200c supports the survival and differentiation of cultured neurons. AD is a progressive neurodegenerative disease signified by beta amyloid (Aβ) peptide aggregation and deposition. In a mouse model of AD that is induced by and Δ double transgenes, we found Aβ deposition results in neuronal ER stress that induces miR200c. Pharmacological blockade of ER stress inhibited Aβ-induced miR-200c overexpression in AD brains. MiR-200c was detected in the serum of both AD mice and human AD patients. These findings suggest that miR-200c functions as part of the neuronal cell-intrinsic adaptive machinery, and supports neuronal survival and differentiation in response to Aβ induced ER-stress by downregulating PTEN.

Citing Articles

Insights into the Role of microRNAs as Clinical Tools for Diagnosis, Prognosis, and as Therapeutic Targets in Alzheimer's Disease.

Puranik N, Song M Int J Mol Sci. 2024; 25(18).

PMID: 39337429 PMC: 11431957. DOI: 10.3390/ijms25189936.


MicroRNAs: pioneering regulators in Alzheimer's disease pathogenesis, diagnosis, and therapy.

Li Y, Fu Q, Guo M, Du Y, Chen Y, Cheng Y Transl Psychiatry. 2024; 14(1):367.

PMID: 39256358 PMC: 11387755. DOI: 10.1038/s41398-024-03075-8.


MicroRNA biomarkers as next-generation diagnostic tools for neurodegenerative diseases: a comprehensive review.

Azam H, Rossling R, Geithe C, Khan M, Dinter F, Hanack K Front Mol Neurosci. 2024; 17:1386735.

PMID: 38883980 PMC: 11177777. DOI: 10.3389/fnmol.2024.1386735.


Regulatory Non-coding RNAs Involved in Oxidative Stress and Neuroinflammation: An Intriguing Crosstalk in Parkinson's Disease.

Khish N, Ghiasizadeh P, Rasti A, Moghimi O, Zadeh A, Bahiraee A Curr Med Chem. 2023; 31(34):5576-5597.

PMID: 37592769 DOI: 10.2174/0929867331666230817102135.


MicroRNAs in Age-Related Proteostasis and Stress Responses.

Matai L, Slack F Noncoding RNA. 2023; 9(2).

PMID: 37104008 PMC: 10143298. DOI: 10.3390/ncrna9020026.


References
1.
Querfurth H, LaFerla F . Alzheimer's disease. N Engl J Med. 2010; 362(4):329-44. DOI: 10.1056/NEJMra0909142. View

2.
Jurgensen S, Ferreira S . Nicotinic receptors, amyloid-beta, and synaptic failure in Alzheimer's disease. J Mol Neurosci. 2009; 40(1-2):221-9. DOI: 10.1007/s12031-009-9237-0. View

3.
Rattray M . Is there nicotinic modulation of nerve growth factor? Implications for cholinergic therapies in Alzheimer's disease. Biol Psychiatry. 2001; 49(3):185-93. DOI: 10.1016/s0006-3223(00)01047-7. View

4.
Logue S, Cleary P, Saveljeva S, Samali A . New directions in ER stress-induced cell death. Apoptosis. 2013; 18(5):537-46. DOI: 10.1007/s10495-013-0818-6. View

5.
Choi P, Zakhary L, Choi W, Caron S, Alvarez-Saavedra E, Miska E . Members of the miRNA-200 family regulate olfactory neurogenesis. Neuron. 2008; 57(1):41-55. PMC: 2204047. DOI: 10.1016/j.neuron.2007.11.018. View